Usana Health Sciences Inc
(USNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | USNA | AKBA | ACRS | ||
| Company | Usana Health Sciences Inc | Akebia Therapeutics | Aclaris Therapts | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 21.21 | 1.5500 | 3.42 | ||
| High | 21.21 | 1.6000 | 3.43 | ||
| Low | 20.62 | 1.3300 | 3.25 | ||
| Latest | 20.96 | 1.3600 | 3.36 | ||
| Change | -0.18 | -0.1900 | -0.03 | ||
| % Change | -0.85% | -12.26% | -0.88% | ||
| Volume | 104,400 | 6,830,600 | 701,800 | ||
| 20-Day Average Volume | 109,290 | 3,347,310 | 3,137,515 | ||
| Previous Close | 21.14 | 1.5500 | 3.39 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 21.59 | 1.4155 | 3.65 | ||
| 20-Day Raw Stochastic | 27.07% | 20.00% | 32.89% | ||
| 20-Day Relative Strength | 49.46 | 42.14 | 50.74 | ||
| Weighted Alpha | -28.62 | -48.72 | +15.28 | ||
| Today's Opinion | 48% Sell | 96% Sell | 88% Buy | ||
| Previous Opinion | 48% Sell | 64% Sell | 88% Buy | ||
| Last Month's Opinion | 48% Sell | 100% Sell | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.72% since 02/05/26 | -1.45% since 02/05/26 | -0.88% since 02/05/26 | ||
| Low | 20.57 on 02/09/26 | 1.3300 on 02/12/26 | 3.25 on 02/12/26 | ||
| High | 22.06 on 02/10/26 | 1.6000 on 02/12/26 | 3.78 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | +1.75% since 01/12/26 | -2.86% since 01/12/26 | +26.32% since 01/12/26 | ||
| Low | 20.19 on 01/13/26 | 1.3000 on 01/20/26 | 2.59 on 01/13/26 | ||
| High | 22.90 on 01/22/26 | 1.6000 on 02/12/26 | 4.89 on 01/20/26 | ||
| 3-Month | |||||
| %Chg | +8.15% since 11/12/25 | -26.49% since 11/12/25 | +39.42% since 11/12/25 | ||
| Low | 18.48 on 11/19/25 | 1.3000 on 01/20/26 | 2.25 on 11/14/25 | ||
| High | 22.90 on 01/22/26 | 1.8350 on 11/17/25 | 4.89 on 01/20/26 | ||
| 6-Month | |||||
| %Chg | -30.30% since 08/12/25 | -59.04% since 08/12/25 | +104.88% since 08/12/25 | ||
| Low | 18.48 on 11/19/25 | 1.3000 on 01/20/26 | 1.63 on 08/13/25 | ||
| High | 32.32 on 08/22/25 | 3.3750 on 08/13/25 | 4.89 on 01/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 386,460 | 411,317 | 367,290 | ||
| Shares Outstanding, K | 18,281 | 265,366 | 108,345 | ||
| Annual Sales | 854,500,000 | 160,180,000 | 18,720,000 | ||
| Annual Net Income | 42,030,000 | -69,410,000 | -132,070,000 | ||
| Last Quarter Sales | 213,670,000 | 58,770,000 | 3,300,000 | ||
| Last Quarter Net Income | -6,520,000 | 540,000 | -14,610,000 | ||
| 60-Month Beta | 0.67 | 0.38 | 0.86 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 10/22/25 | 0.00 on 11/10/25 | -0.12 on 11/06/25 | ||
| Latest Earnings Date | 02/17/26 | 03/12/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 10.93 | 0.00 | 0.00 | ||